Skip to main content
. 2020 May 26;6(2):00184-2019. doi: 10.1183/23120541.00184-2019

TABLE 2.

The association between acute exacerbation (AEx) of idiopathic interstitial pneumonias and each suspected cytotoxic agent

Agents Patients AEx
Cisplatin 91 15 (16.5%)
Carboplatin 250 20 (8.0%)
Etoposide 124 7 (5.6%)
Paclitaxel 146 18 (12.3%)
Vinorelbine 51 10 (19.6%)
Docetaxel 19 6 (31.6%)
Gemcitabine 6 1 (16.7%)
Vindesine 17 1 (5.9%)
UFT 17 5 (29.4%)
 Platinum-based regimen 341 35 (10.3%)
 Nonplatinum-based regimen# 49 13 (26.5%)

UFT: tegafur-uracil. #: gefitinib was excluded.